Penel N - Search Results

1

Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period.

Clisant S, Clermont A, Adenis A, Penel N. Clisant S, et al. Among authors: penel n. Contemp Clin Trials. 2012 May;33(3):459. doi: 10.1016/j.cct.2012.02.009. Epub 2012 Feb 16. Contemp Clin Trials. 2012. PMID: 22366776 No abstract available.

2

Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

Penel N, Fournier C, Clisant S, N'Guyen M. Penel N, et al. Among authors: n guyen m. Support Care Cancer. 2004 Aug;12(8):593-8. doi: 10.1007/s00520-004-0602-9. Epub 2004 Feb 10. Support Care Cancer. 2004. PMID: 14770304

3

Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases.

Penel N, Berthon C, Everard F, Neu JC, Clisant S, N'guyen M, Villet S, Fournier C, Lefebvre JL. Penel N, et al. Among authors: n guyen m. Oral Oncol. 2005 Oct;41(9):884-9. doi: 10.1016/j.oraloncology.2005.04.013. Oral Oncol. 2005. PMID: 16043379

4

A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa.

Penel N, Amela EY, Mallet Y, Lefebvre D, Clisant S, Kara A, Neu JC, Everard F, Lefebvre JL. Penel N, et al. Oral Oncol. 2007 Feb;43(2):174-80. doi: 10.1016/j.oraloncology.2006.02.003. Epub 2006 Jul 21. Oral Oncol. 2007. PMID: 16859954

5

Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection.

Penel N, Yazdanpanah Y, Chauvet MP, Clisant S, Giard S, Neu JC, Lefebvre D, Fournier C, Bonneterre J. Penel N, et al. J Surg Oncol. 2007 Aug 1;96(2):124-9. doi: 10.1002/jso.20796. J Surg Oncol. 2007. PMID: 17443747

6

Risk factors for early catheter-related infections in cancer patients.

Penel N, Neu JC, Clisant S, Hoppe H, Devos P, Yazdanpanah Y. Penel N, et al. Cancer. 2007 Oct 1;110(7):1586-92. doi: 10.1002/cncr.22942. Cancer. 2007. PMID: 17685401 Free article.

7

Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis.

Penel N, Dewas S, Doutrelant P, Clisant S, Yazdanpanah Y, Adenis A. Penel N, et al. Support Care Cancer. 2008 Apr;16(4):387-92. doi: 10.1007/s00520-007-0322-z. Epub 2007 Aug 21. Support Care Cancer. 2008. PMID: 17710443

8

Prognostic factors among cancer patients with good performance status screened for phase I trials.

Penel N, Vanseymortier M, Bonneterre ME, Clisant S, Dansin E, Vendel Y, Beuscart R, Bonneterre J. Penel N, et al. Invest New Drugs. 2008 Feb;26(1):53-8. doi: 10.1007/s10637-007-9088-x. Epub 2007 Sep 22. Invest New Drugs. 2008. PMID: 17891337

9

Angiosarcomas and taxanes.

Penel N, Lansiaux A, Adenis A. Penel N, et al. Curr Treat Options Oncol. 2007 Dec;8(6):428-34. doi: 10.1007/s11864-007-0042-0. Epub 2007 Dec 8. Curr Treat Options Oncol. 2007. PMID: 18066504 Review.

10

[Methodological approaches of clinical studies with targeted therapies].

Penel N, Saleron J, Lansiaux A, Clisant S, Adenis A, Fournier C, Duhamel A, Bonneterre J. Penel N, et al. Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Bull Cancer. 2008. PMID: 18304903 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters